# Taking a GLP-1 Like Ozempic? These Health Risks Are Higher in the Heat
Parents using GLP-1 medications like Ozempic, Wegovy, or Mounjaro need to take extra precautions during summer months. These drugs increase dehydration risk and reduce the body's ability to regulate temperature, creating a dangerous combination in hot weather.
GLP-1 receptor agonists work by slowing gastric emptying and reducing appetite. This mechanism has an unintended side effect: decreased thirst signals. Users often drink less water without realizing it, leading to dehydration that becomes more pronounced in heat.
Heat also impacts how the body cools itself. GLP-1 medications can impair sweating and heat dissipation, making overheating more likely during exercise or outdoor activities. Dehydration combined with reduced cooling capacity increases risks for heat exhaustion and heat stroke.
Parents taking these medications should drink water consistently throughout the day, not just when thirsty. Set phone reminders if needed. Limit strenuous outdoor activity during peak heat hours, typically 10 a.m. to 4 p.m. Wear lightweight, breathable clothing and take frequent breaks in air-conditioned spaces.
Watch for warning signs of heat-related illness: dizziness, nausea, excessive fatigue, confusion, or rapid heartbeat. These symptoms demand immediate cooling and medical attention.
Talk with your prescribing doctor before summer about your specific medication and heat safety. Some people may need to adjust dosing or activity levels during hot months. Parents should also teach children to recognize heat illness symptoms and report them immediately.
The combination of GLP-1 medication and summer heat requires active management. Simple precautions—planned hydration, timing activities carefully, recognizing symptoms—make these medications safe and